BeStock  
Markets › Compare › COLB vs SYRE

COLB vs SYRE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
COLB · Columbia Banking System$28.84 ▼ 0.28%
SYRE · Spyre Therapeutics$92.72 ▼ 0.50%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

57221386551715Oct 7, '25Apr 7, '26Oct 5, '26
  • COLB +15.8%
  • SYRE +478.8%

Head to head

MetricCOLBSYRE
Price$28.84$92.72
Change today▼ 0.28%▼ 0.50%
Market cap$8.16B$8.18B
Return, 3 months-9.1%-1.6%
Return, year to date+7.1%+183.0%
Return, 1 year+14.1%+456.2%
P/E (TTM)11.4-46.8
P/B1.18.6
P/E percentile vs own 5y––
Dividend yield5.10%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)3953
30-day volatility18.1%52.0%
Max drawdown, 1 year-18.4%-22.2%
Trend readStrong downtrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • SYRE is the largest of the group by market value.
  • SYRE has returned the most over the past year.
  • SYRE carries the lowest trailing P/E.
  • COLB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top